Effect of 2-hydroxypropyl-β-cyclodextrin on release rate of metoprolol from ternary metoprolol/2-hydroxypropyl-β-cyclodextrin/ethylcellulose tablets

被引:15
作者
Ikeda, Y
Motoune, S
Marumoto, A
Sonoda, Y
Hirayama, F
Arima, H
Uekama, K
机构
[1] Fac Pharmaceut Sci, Kumamoto 8620973, Japan
[2] Wakunaga Pharmceut Co Ltd, Inst Healthcare Res, Hiroshima 7391195, Japan
关键词
ethylcellulose; gel; 2-hydroxypropyl-beta-cyclodextrin; metoprolol; release control; tablet;
D O I
10.1023/A:1023082226992
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The effect of 2-hydroxypropyl-beta-cyclodextrin (HP-beta-CyD) on the release of a water-soluble beta(1)-selective adrenoreceptor antagonist, metoprolol ( Met), from ternary Met/HP-beta-CyD/ethylcellulose (EC) tablets was investigated. The release rate of Met from the ternary tablets was dependent on amounts of HP-beta-CyD in the tablets, i.e., the rate decreased when small amounts of HP-beta-CyD were added, while large amounts of HP-beta-CyD accelerated the rate. The slowest rate was observed for the tablet consisted of a 30/10/60 weight ratio of Met/HP-beta-CyD/EC. The analyses of the release rates by the Korsmeyer equation and their temperature dependence suggested that Met is released from the EC matrix containing HP-beta-CyD according to the diffusion-controlled mechanism. The water penetration studies and the micro- and macroscopic observations suggested that the retarding effect of HP-beta-CyD is attributable to a viscous gel formation in small pores on the surface of the tablets, where HP-beta-CyD gels may work as a barrier for the water penetration into the tablets and the release of the drug from the tablets. The in-vitro release property of the ternary tablets was reflected in the in-vivo absorption profile in dogs. The results indicated that a combination of HP-beta-CyD and EC is useful for the release control of water-soluble drugs such as Met.
引用
收藏
页码:141 / 144
页数:4
相关论文
共 9 条
[1]  
HIRAYAMA F, 1987, METHODS INVESTIGATIN, P131
[2]   SLOW-RELEASE CHARACTERISTICS OF DILTIAZEM FROM ETHYLATED BETA-CYCLODEXTRIN COMPLEXES [J].
HORIUCHI, Y ;
HIRAYAMA, F ;
UEKAMA, K .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1990, 79 (02) :128-132
[3]   Controlled release of a water-soluble drug, captopril, by a combination of hydrophilic and hydrophobic cyclodextrin derivatives [J].
Ikeda, Y ;
Kimura, K ;
Hirayama, F ;
Arima, H ;
Uekama, K .
JOURNAL OF CONTROLLED RELEASE, 2000, 66 (2-3) :271-280
[4]   MECHANISMS OF SOLUTE RELEASE FROM POROUS HYDROPHILIC POLYMERS [J].
KORSMEYER, RW ;
GURNY, R ;
DOELKER, E ;
BURI, P ;
PEPPAS, NA .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1983, 15 (01) :25-35
[5]   Pharmaceutical applications of cyclodextrins .1. Drug solubilization and stabilization [J].
Loftsson, T ;
Brewster, ME .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (10) :1017-1025
[6]   Effect of cyclodextrins and polymers on triclosan availability and substantivity in toothpastes in vivo [J].
Loftsson, T ;
Leeves, N ;
Bjornsdottir, B ;
Duffy, L ;
Masson, N .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 88 (12) :1254-1258
[7]  
NOGAMI H, 1966, CHEM PHARM BULL, V14, P329
[8]  
Soliman O.A., 1996, PHARM SCI, V2, P533
[9]   DESIGN AND IN-VITRO EVALUATION OF A MODIFIED-RELEASE ORAL DOSAGE FORM OF NIFEDIPINE BY HYBRIDIZATION OF HYDROXYPROPYL-BETA-CYCLODEXTRIN AND HYDROXYPROPYLCELLULOSE [J].
WANG, Z ;
HORIKAWA, T ;
HIRAYAMA, F ;
UEKAMA, K .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1993, 45 (11) :942-946